Evidence map›Paper›PMID 36703761›Full record

ReviewFrontiers in pharmacology2022

Uterine fibroids - Causes, impact, treatment, and lens to the African perspective.

Narvella Sefah, Sithembinkosi Ndebele, Lillian Prince, Elizabeth Korasare, Michael Agbleke, Annabella Nkansah, Humphrey Thompson, Ayman Al-Hendy, Andrews Akwasi Agbleke

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Pharmacological activities ofFrontiers in pharmacology · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Narvella SefahUniversity of Chicago, Chicago, United States.
Sithembinkosi NdebeleUniversity of Chicago, Chicago, United States.
Lillian PrinceUniversity of Chicago, Chicago, United States.
Elizabeth KorasareFibroid Foundation Africa, Accra, Ghana.
Michael AgblekeSena Institute of Technology, Penyi, Ghana.
Annabella NkansahSena Institute of Technology, Penyi, Ghana.
Humphrey ThompsonSena Institute of Technology, Penyi, Ghana.
Ayman Al-HendyUniversity of Chicago, Chicago, United States.
Andrews Akwasi AgblekeSena Institute of Technology, Penyi, Ghana.
Accra Institute of Technology · GHUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leiomyomas, or uterine fibroids as they are commonly known, are mostly seen in women of reproductive age. However, they can go undetected in most women, and approximately 25% of women show clinical symptoms. Although fibroids are a global burden impacting 80% of premenopausal women, they are more prevalent among Black women than among women of other races. Based on clinical diagnosis, the estimated cumulative incidence of fibroids in women ≤50 years old is significantly higher for black (>80%)

Indexed as

Africacauses and treatmentfibroidlifestyleperspectiveracetypes and classification

Identifiers

PMID36703761
PMCPMC9871264
OpenAlexW4315474356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.